stockrowAkebia Therapeutics, Inc. (AKBA) vs Journey Medical Corporation (DERM)
- Akebia Therapeutics, Inc. AKBA 0.43 −37.68%
- Journey Medical Corporation DERM 4.30 −9.09%
Akebia Therapeutics, Inc. and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. Akebia Therapeutics, Inc. and Journey Medical Corporation are of similar size ($121.4M and $117.9M). Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −12.4%. Journey Medical Corporation has the higher net margin (−8.95% vs −22.6%) and the lower return on invested capital (−5.89% vs 0.00%). Across the 18 metrics below, Journey Medical Corporation leads on 10 and Akebia Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | AKBA | DERM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 78.90% | 65.45% | 53.51% |
| Operating margin | (15.74%) | (4.41%) | 0.00% |
| Net margin | (22.60%) | (8.95%) | (2.45%) |
| Free cash flow margin | 7.03% | (10.99%) | 0.00% |
| Return on equity | (143.83%) | (23.77%) | (0.80%) |
| Return on assets | (12.62%) | (6.80%) | (1.67%) |
| Return on invested capital | 0.00% | (5.89%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack